With increasing choice of medications and devices for asthma and chronic obstructive
pulmonary disease (COPD) treatment, comparative evidence may inform treatment …

Rationale: Current Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy
recommends the combination of two long-acting bronchodilators of different pharmacologic …

Background Patients with COPD may be prescribed multiple inhalers as part of their
treatment regimen, which require different inhalation techniques. Previous literature has …

Despite significant advances in treatment, chronic obstructive pulmonary disease (COPD)
remains a chronic and progressive disease that frequently leads to premature mortality …

Background The long-term safety and efficacy of a novel Co-Suspension™ Delivery
Technology glycopyrrolate (GP)/formoterol fumarate (FF) 18/9.6 μg fixed-dose combination …

Importance Clinical guidelines on chronic obstructive pulmonary disease (COPD)
recommend inhalers containing long-acting muscarinic antagonists (LAMAs) and long …

This gamma scintigraphy imaging study was the first to assess pulmonary and extrathoracic
deposition and regional lung deposition patterns of a radiolabelled long-acting muscarinic …

Introduction Chronic obstructive pulmonary disease (COPD) guidelines recommend
reserving triple therapy of inhaled corticosteroid (ICS), long-acting β2-agonist (LABA) and …

Background Asthma requires individually tailored and careful management to control and
prevent symptoms and exacerbations. Selection of the most appropriate treatment is …

Purpose Real-word evidence on the effectiveness of switching from dual therapies or triple
therapies (multiple inhalers) to extrafine single-inhaler triple therapy (efSITT), which consists …